Clinical trial
Non-interventional Prospective Study of Safety and Efficacy of the Drug Cycloferone® (NTFF "POLYSAN" Ltd., Russia) in Patients with Acute Respiratory Viral Infection At the Outpatient Stage
NCT06286254 is registered in ClinicalTrials.gov with POLYSAN Scientific & Technological Pharmaceutical Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Prospective Study of Safety and Efficacy of the Drug Cycloferone® (NTFF "POLYSAN" Ltd., Russia) in Patients with Acute Respiratory Viral Infection At the Outpatient Stage
- Lead sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2023
- Completion date
- September 30, 2024
- Enrollment
- 742 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory viral infection